Digital repository of Slovenian research organisations

Show document
A+ | A- | Help | SLO | ENG

Title:From crisis to routine – standardization of SARS-CoV-2 genome detection by enhanced EQA schemes in a scientific pandemic network
Authors:ID Kammel, Martin (Author)
ID Grunert, Hans-Peter (Author)
ID Zimmermann, Anika (Author)
ID Martin, Annemarie (Author)
ID Lindig, Vanessa (Author)
ID Milavec, Mojca (Author)
Files:URL URL - Source URL, visit https://doi.org/10.1016/j.ijmm.2025.151656
 
.pdf PDF - Presentation file, download (10,30 MB)
MD5: 35244153C26B6E70E6037E6D16E6DEE7
 
.zip ZIP - Supplement, download (733,09 KB)
MD5: B3E3EBDE61ED2AEBBDACA7AC724633B4
Description: Supplementary material
 
Language:English
Typology:1.01 - Original Scientific Article
Organization:Logo NIB - National Institute of Biology
Abstract:In the beginning of 2020, the outbreak of the COVID-19 pandemic led to a crisis in which diagnostic methods for the genome detection of SARS-CoV-2 were urgently needed. Based on the very early publication of the basic principles for a diagnostic test for the genome detection of SARS-CoV-2, the first noncommercial laboratory-developed tests (LDTs) and commercial tests were introduced. As there was considerable uncertainty about the reliability and performance of different tests and different laboratories, INSTAND established external quality assessment (EQA) schemes for the detection of SARS-CoV-2 starting in April 2020. In close partnership in a scientific network, the EQA schemes were enhanced, especially the April, June and November 2020 terms. The enhancement included: (i) immediate provision of suitable virus including variants of concern at the beginning of the pandemic outbreak, (ii) short frequency of EQA schemes, (iii) concentration dependency of the testing and sensitivity check, achieved by using SARS-CoV-2-positive samples from a 10-fold dilution series of the same starting material, (iv) specificity check of the testing, achieved by using SARS-CoV-2-negative samples containing human coronaviruses or MERS CoV, (v) revealed samples for orientation on test performance during an ongoing or at the start of an EQA scheme using a pre-quantified SARS-CoV-2-positive EQA sample with a low viral RNA load of only 1 570 copies/mL assigned by digital PCR (dPCR) in June 2020 and (vi) quantified reference materials based on the experiences of the first two EQA schemes with dPCR-assigned values in copies/mL beginning in November 2020 for self-evaluation of the applied test system. This manuscript summarizes the results of a total of 13 EQA schemes for the detection of SARS-CoV-2 between April 2020 and June 2023 in which a total of 1 413 laboratories from 49 countries participated. The qualitative results for the detection of SARS-CoV-2-positive samples were between 95.8 % and 99.7 % correct positive, excluding extremely low concentration samples. For all SARS-CoV-2-negative EQA samples, the qualitative success rates ranged from 95.1 % to 99.4 % correct negative results. The widely varying values for the cycle threshold (Ct)/crossing point (Cq) reported for the different target genes and test systems were striking. A few laboratories reported quantitative results in copies/mL for several VOCs with an acceptable rate of over 93 % correct positive results in the majority of cases. The description of the enhanced EQA schemes for SARS-CoV-2 detection in terms of timing and scope can serve as a blueprint for the rapid development of a quality assessment of diagnostics for an emerging pathogen.
Keywords:COVID-19 pandemic, SARS-CoV-2, virus genome detection tests, reference materials, external quality assessment, laboratory medicine, epidemiology
Publication status:Published
Publication version:Version of Record
Publication date:01.06.2025
Year of publishing:2025
Number of pages:str. 1-24
Numbering:Vol. 319, [art. no.] ǂ151656
PID:20.500.12556/DiRROS-22722 New window
UDC:578
ISSN on article:1438-4221
DOI:10.1016/j.ijmm.2025.151656 New window
COBISS.SI-ID:239799299 New window
Note:Soavtorica iz Slovenije: Mojca Milavec;
Publication date in DiRROS:18.06.2025
Views:502
Downloads:450
Metadata:XML DC-XML DC-RDF
:
Copy citation
  
Share:Bookmark and Share


Hover the mouse pointer over a document title to show the abstract or click on the title to get all document metadata.

Record is a part of a journal

Title:International journal of medical microbiology
Shortened title:Int J Med Microbiol
Publisher:Urban & Fischer
ISSN:1438-4221
COBISS.SI-ID:2144788 New window

Document is financed by a project

Funder:German Federal Ministry of Health

Licences

License:CC BY-NC-ND 4.0, Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International
Link:http://creativecommons.org/licenses/by-nc-nd/4.0/
Description:The most restrictive Creative Commons license. This only allows people to download and share the work for no commercial gain and for no other purposes.

Secondary language

Language:Slovenian
Title:From crisis to routine
Keywords:pandemija COVID-19, SARS-CoV-2, testi za odkrivanje genoma virusa, referenčni materiali, zunanja ocena kakovosti, laboratorijska medicina, epidemiologija


Back